Advisors Asset Management, Inc. Biogen Inc. Transaction History

Advisors Asset Management, Inc.

$5.34 Billion
Q2 2025

A detailed history of Advisors Asset Management, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 5,713 shares of BIIB stock, worth $812,731. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,713

Previous 6,384 10.51%

Holding current value

$812,731

Previous $873,000 17.87%

% of portfolio

0.01%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$113.38 - $135.49 $76,077 - $90,913	-671 Reduced 10.51%	5,713 $717,000
Q1 2025 May 15, 2025	SELL	$133.43 - $153.27 $31,889 - $36,631	-239 Reduced 3.61%	6,384 $873,000
Q4 2024 Feb 10, 2025	SELL	$146.47 - $191.55 $10,692 - $13,983	-73 Reduced 1.09%	6,623 $1.01 Million
Q3 2024 Nov 08, 2024	BUY	$189.07 - $236.8 $27,793 - $34,809	147 Added 2.24%	6,696 $1.3 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $169,943 - $211,154	-892 Reduced 11.99%	6,549 $1.52 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $95,621 - $120,737	451 Added 6.45%	7,441 $1.6 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $245,739 - $295,805	1,104 Added 18.76%	6,990 $1.81 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $157,443 - $181,930	572 Added 10.76%	5,886 $1.68 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $40,536 - $46,189	-158 Reduced 2.89%	5,314 $1.48 Million
Q3 2022 Nov 08, 2022	BUY	$194.69 - $268.46 $65,221 - $89,934	335 Added 6.24%	5,706 $1.52 Million
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $187,164 - $222,573	998 Added 22.82%	5,371 $1.1 Million
Q1 2022 May 17, 2022	SELL	$193.77 - $244.14 $176,524 - $222,411	-911 Reduced 17.24%	4,373 $921,000
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $52,845 - $67,913	236 Added 4.68%	5,284 $1.27 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $15,564 - $20,297	55 Added 1.1%	5,048 $1.43 Million
Q2 2021 Jul 30, 2021	BUY	$259.0 - $414.71 $131,313 - $210,257	507 Added 11.3%	4,993 $1.73 Million
Q1 2021 May 07, 2021	BUY	$242.95 - $284.63 $330,412 - $387,096	1,360 Added 43.51%	4,486 $1.26 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $345,412 - $519,931	1,462 Added 87.86%	3,126 $765,000
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $20,122 - $23,233	76 Added 4.79%	1,664 $472,000
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $94,669 - $125,373	-366 Reduced 18.73%	1,588 $425,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $131,198 - $166,427	-488 Reduced 19.98%	1,954 $618,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $125,434 - $173,319	-570 Reduced 18.92%	2,442 $725,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $325,290 - $364,844	-1,496 Reduced 33.19%	3,012 $701,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $128,284 - $141,406	-585 Reduced 11.49%	4,508 $1.05 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $278,905 - $436,241	-1,287 Reduced 20.17%	5,093 $1.2 Million
Q4 2018 Jan 31, 2019	SELL	$278.5 - $352.75 $2.2 Million - $2.78 Million	-7,887 Reduced 55.28%	6,380 $1.92 Million
Q3 2018 Nov 15, 2018	SELL	$293.51 - $383.83 $243,319 - $318,195	-829 Reduced 5.49%	14,267 $5.04 Million
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $287,134 - $342,204	1,115 Added 7.98%	15,096 $4.38 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $46,563 - $65,855	179 Added 1.3%	13,981 $4.03 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $143,052 - $160,229	465 Added 3.49%	13,802 $4.4 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $3.75 Million - $4.4 Million	13,337	13,337 $4.18 Million

Others Institutions Holding BIIB

# of Institutions

1,022

Shares Held

131M

Call Options Held

2.84M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Biogen Inc. Transaction History